Physician
August, Carey
August, Carey was paid $1.89M by Medicaid between Jan 2018 and Oct 2023, across 111 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 15% of everything it billed.
33Billing provider infoAUGUST, CAREY
LOMBARD, IL 60148
LOMBARD, IL 60148
33aNPI1265424725assigned 08/19/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.89M
24GClaims332,314
24DCodes billed111
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#41 of 398
Median peer was paid$66K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 305 | $6K | |
| 2019 | 6,522 | $38K | |
| 2020 | 85,127 | $406K | |
| 2021 | 79,658 | $444K | |
| 2022 | 89,867 | $585K | |
| 2023 | 70,835 | $408K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 15% | 3,714 | 3,527 | $275K |
| 80053 | Comprehensive metabolic panel | 11% | 39,773 | 25,141 | $200K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.6% | 55,923 | 32,218 | $162K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.2% | 6,513 | 5,850 | $155K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.5% | 20,349 | 10,116 | $85K |
| 83735 | 3.6% | 18,033 | 8,156 | $68K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.9% | 1,002 | 786 | $54K |
| 84484 | 2.4% | 11,766 | 9,085 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.4% | 1,960 | 1,801 | $45K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.3% | 1,951 | 1,795 | $44K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.3% | 1,630 | 1,497 | $44K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 1,645 | 1,330 | $43K |
99 more codes
| 83880 | 1.9% | 3,185 | $36K | |
| 87040 | 1.8% | 3,564 | $34K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 3,618 | $31K |
| 83605 | 1.6% | 6,768 | $31K | |
| 85027 | 1.6% | 10,295 | $30K | |
| 83690 | 1.3% | 7,329 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 4,332 | $24K |
| 85730 | 1.2% | 6,771 | $22K | |
| 86850 | 1.1% | 7,220 | $21K | |
| 82803 | 1.1% | 2,254 | $21K | |
| 86901 | 1.1% | 8,900 | $20K | |
| 88307 | 1.0% | 276 | $19K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 536 | $19K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 325 | $17K |
| 85610 | <1% | 7,488 | $15K | |
| 86900 | <1% | 8,901 | $15K | |
| 84100 | <1% | 6,739 | $15K | |
| 82805 | <1% | 1,334 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 618 | $14K |
| 81001 | <1% | 9,162 | $13K | |
| 85379 | <1% | 2,973 | $12K | |
| 82728 | <1% | 2,839 | $11K | |
| 82077 | <1% | 1,011 | $10K | |
| 87641 | <1% | 410 | $9K | |
| 82330 | <1% | 1,289 | $9K | |
| 83550 | <1% | 2,019 | $9K | |
| 83615 | <1% | 2,963 | $8K | |
| 86140 | <1% | 3,355 | $8K | |
| 84702 | <1% | 1,706 | $8K | |
| 82607 | <1% | 1,153 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,091 | $7K |
| 80061 | Lipid panel | <1% | 1,862 | $6K |
| 82746 | <1% | 1,067 | $6K | |
| 84145 | <1% | 784 | $6K | |
| 82550 | <1% | 1,828 | $5K | |
| 87075 | <1% | 780 | $5K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 208 | $5K |
| 84703 | <1% | 1,373 | $5K | |
| 87340 | <1% | 672 | $4K | |
| 86706 | <1% | 617 | $4K | |
| 86704 | <1% | 552 | $4K | |
| 87210 | <1% | 1,788 | $4K | |
| 87070 | <1% | 1,236 | $4K | |
| 82247 | <1% | 1,825 | $4K | |
| 81003 | <1% | 3,663 | $4K | |
| 82248 | <1% | 1,959 | $4K | |
| 82570 | <1% | 1,354 | $3K | |
| 82375 | <1% | 1,196 | $3K | |
| 86592 | <1% | 1,472 | $3K | |
| 87806 | <1% | 296 | $3K | |
| 88304 | <1% | 235 | $3K | |
| 84550 | <1% | 1,451 | $3K | |
| 80076 | <1% | 732 | $3K | |
| 86880 | <1% | 850 | $3K | |
| 87205 | <1% | 1,346 | $2K | |
| 85652 | <1% | 1,783 | $2K | |
| 85018 | <1% | 2,208 | $2K | |
| 83050 | <1% | 1,282 | $2K | |
| 87088 | <1% | 349 | $2K | |
| 85046 | <1% | 680 | $2K | |
| 88342 | <1% | 133 | $2K | |
| 82378 | <1% | 261 | $2K | |
| 87186 | <1% | 259 | $2K | |
| 84439 | <1% | 345 | $2K | |
| 84132 | <1% | 709 | $1K | |
| 82435 | <1% | 973 | $1K | |
| 82947 | <1% | 921 | $1K | |
| 85014 | <1% | 1,027 | $1K | |
| 84295 | <1% | 1,006 | $1K | |
| 84156 | <1% | 1,062 | $1K | |
| 86780 | <1% | 123 | $1K | |
| 80202 | <1% | 156 | $1K | |
| 83540 | <1% | 330 | $1K | |
| 81025 | <1% | 412 | $933.96 | |
| 86300 | <1% | 85 | $857.15 | |
| 86803 | <1% | 97 | $825.16 | |
| 85384 | <1% | 251 | $782.96 | |
| 84300 | <1% | 309 | $683.08 | |
| 82962 | <1% | 587 | $640.17 | |
| 86304 | <1% | 54 | $591.70 | |
| 83930 | <1% | 235 | $587.16 | |
| 87081 | <1% | 185 | $521.65 | |
| 86920 | <1% | 76 | $378.35 | |
| 87493 | <1% | 15 | $340.85 | |
| 82150 | <1% | 90 | $298.66 | |
| 80164 | <1% | 46 | $241.66 | |
| 83935 | <1% | 92 | $210.93 | |
| 82140 | <1% | 37 | $161.69 | |
| 86308 | <1% | 44 | $105.60 | |
| 86038 | <1% | 12 | $94.80 | |
| 82272 | <1% | 76 | $92.38 | |
| 87077 | <1% | 223 | $91.38 | |
| 87807 | <1% | 16 | $75.45 | |
| 89051 | <1% | 14 | $43.40 | |
| 87102 | <1% | 13 | $40.30 | |
| 82565 | <1% | 16 | $32.62 | |
| 87206 | <1% | 15 | $31.50 | |
| 84155 | <1% | 14 | $28.80 | |
| 80320 | 0% | 864 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.